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duration of dialysis before or after transplantation, method or
duration of preservation of the donor kidney or amount of pred-
nisone received. Twelve of the 16 patients (75%) living in the
immediate vicinity of Rotterdam developed AVN as compared to
six of 28 (2 1%) living elsewhere. This suggests than an environmen-
tal factor, such as water supply, may be contributing to the high
incidence of AVN at EU.
Plasma-exchange and immunosuppression in the treatment of
Goodpasture's syndrome. C. M. Lockwood, A. J. Rees, Pamela
Ewan, D. K. Peters and C. B. Wilson. Department of Medicine,
Royal Postgraduate Medical School, London, England; and Depart-
ment of Experimental Pathology, Scripps Clinic and Research Foun-
dation, La Jolla, California. Eight patients with Goodpasture's
syndrome, all of whom had demonstrable circulating antibody to
glomerular basement membrane (GBM) as detected by radio-
immunoassay, were treated by a regime of intensive plasma-ex-
change, cytotoxic drugs and steroids. Four patients had some renal
function at presentation and in three of these there was improve-
ment in renal function and termination of anti-GBM antibody
synthesis following this therapeutic regime. The fourth patient, at
present in the second week of treatment, is showing improvement
in renal function and fall in anti-GBM antibody titer. The other
four patients were anuric at presentation and all had extensive
changes on renal biopsy. No return of renal function occurred in
this group and anti-GBM antibody levels, although reduced by the
combination of plasma-exchange, cytotoxic drugs and steroids,
remained elevated. Pulmonary hemorrhage was a feature at pre-
sentation in six patients and in one was severe and life-threatening.
In this patient and four others, lung bleeding was arrested soon
after the start of therapy. In a further patient, currently undergoing
therapy, hemoptysis has stopped after one week's treatment. The
"deglobulinating" effect of plasma-exchange using purified protein
fraction, leading to depletion of fibrinogen, complement and im-
munoglobulins will be discussed.
Clolibrate-induced muscle damage in patients with chronic renal
failure. A. M. Pierides. F. Alvarez- Ude and D. N. S. Kerr. Depart-
ment of Medicine, University of Newcastle upon Tyne, England.
Four patients in chronic renal failure who were given I to 2 g of
clotibrate daily developed a hypercatabolic state and a clinical
syndrome characterized by widespread muscle weakness and ten-
derness, particularly affecting proximal muscles. Muscle enzymes
such as creatinine kinase rose significantly to up to 8,000 U/liter. Two
patients with advanced but static renal failure (serum creatinine, 9
to 12 mg/l00 ml) deteriorated rapidly with a rise in serum urea and
creatinine and required early dialysis. Renal function did not re-
cover in these two patients when clofibrate was withdrawn and at
present one of the patients continues on regular hemodialysis while
the other patient, who was a poor regular hemodialysis patient,
died a few weeks later. One patient with mild renal failure (serum
creatinine, 3.5 mg/l00 ml) recovered fully when clofibrate was
withdrawn. One anephric patient already on regular hemodialysis
developed the clinical syndrome and also a marked paradoxical
rise in cholesterol and fasting triglycerides up to 3.5 g/lOO ml.
Serum chlorophenoxyisobutyric acid (CPIB), the circulating active
metabolite of clofibrate, was estimated serially in two of the
patients and was found to be markedly elevated, outside the thera-
peutic range. It is thought that high serum levels of this compound
are responsible for the observed side effects. It is suggested that
uremia leads to accumulation of CPIB with a rise in the free
circulating fraction. Under these circumstances, clofibrate should
be used very cautiously indeed, ensuring an appropriate reduction
in dosage according to residual renal function. Regular monitoring
with serum muscle enzymes and CPIB are advisable.
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Efficacy of petroleum charcoal hemoperfusion and acetate-free
dialysate in eight patients with hepatic coma. I. Amano, H. Kano, S.
iwatsuki, H. Takahira, K. Ohta and K. Maeda. Chukyo Hospital
and The Biodynamics Research Institute, Nagoya, Japan. Although
the pathogenesis of hepatic coma is complicated, we have tried to
save patients by eliminating encephalogenic substances and cor-
recting electrolytes and p1-I. Our artificial liver assist is a combina-
tion of petroleum charcoal hemoperfusion and hemoperfusion us-
ing acetate-free dialysate. The feature of petroleum pitch charcoal
is that it releases small amounts of 1.2 to 5.0 t pulverized carbon.
It shows excellent adsorption in Vitro for methionine of amino
acids, short chain fatty acid and some annuli amins. Two cases of
eight patients were advanced posthepatic cirrhosis and one of them
had a porta caval shunt. The remaining six cases were fulminant
viral hepatitis. Seven of the eight patients with grade 3 to 4 coma
recovered consciousness and three of them survived. Dialysate was
free of acetate which was affected more by charcoal adsorption
than bicarbonate. Bicarbonate contained in dialysate could correct
pH stabler than acetate. Our experience shows that independently
the charcoal hemoperfusion and the body fluid correction device
cannot be effectively used. Reproduction of liver tissues, in histo-
logical study, was observed in spite of considerable hemoperfusion
as many as ten times. No emboli of pulverized carbon were seen in
the lungs, liver, spleen or kidneys.
A full account of the meeting will appear in the Proceedings of the
EDTA by January /976. AB Gambro (Sweden) has kindly assisted
with the publication of the abstracts. Only those abstracts that have
been selected for presentation are included.
Accumulation and excretion of middle molecules. H. Asaba, J.
Bergstrom, P. FOrst and L. Zimmerman. Department of Nephrology.
S:t Eriks sjukhus, Stockholm, Sweden. There is evidence that poten-
tially toxic middle molecules (MM) accumulate in uremia, but
little is known about their rate of generation and excretion. By
using gel filtration combined with gradient elution chromatogra-
phy, we evaluated quantitatively the concentration of MM frac-
tions (7a, b, c) from the integrated peak areas of the chromato-
grams. Plasma and urine from patients with varying degrees of
renal failures were analyzed. Among 85 patients studied, measur-
able plasma peaks were only found when serum creatinine was
above 6 mg/l00 ml or creatinine clearance (Kr) below 10 mI/mm.
No correlation was found between serum urea and serum creati-
nine and the accumulation of fraction 7a, bore. There was a linear
correlation between Ker and the renal clearance of 7a, band c (K7a,
K7b, K7). K?b and K7 were on average equal to Ker; K7a was
higher indicating either some tubular excretion or production by
the kidney. The rates of excretion of individual MM in the urine
varied considerably among different patients; peaks found high in
plasma were also found high in the urine. Taking excretion rate to
be equal to generation rate, the results indicate that great differ-
ences in production (by a factor of 5 or more) are more important
for the accumulation of MM than passive retention. This also
explains the lack of correlation with serum urea and serum creati-
nine. In consequence, mathematical models for calculating the
level of MM based on the assumption of a constant production
rate will give erroneous results.
Wrist watch-size single-needle clamping device. R. A. Baillod, C.
M. Roberts, J. F. Moorhead, Z. Varghese and A. Peacock. Renal
Unit, Royal Free Hospital, London, England. Recent technical ad-
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vances in dialysis have been attempts to reduce the length of
dialysis by increasing its efficiency and frequency. The standard
blood access is the fistula, and increased frequency of dialysis is not
necessarily acceptable by the patient nor does it aid longevity of
flstual life. This proves the need for a one-needle system and its
development with a view to maintaining or increasing efficiency of
dialysis. Initial experiences with the one-needle system showed its
crudity in allowing the recirculation of the blood resulting in loss
of efficiency and inadequacy of the clamping mechanism resulting
in damage to lines. Review of the situation caused us to define our
requirements and then attempt to design the equipment accord-
ingly. The requirements were clamping at the site of the needle,
small and flexible enough to be strapped like a wrist watch to the
fistula arm, swift but gentle action with momentary delay between
exchange of clamping to prevent recirculation, variable timing.
Total development time was two years. All the research work was
undertaken in the U nit, resulting in various prototypes being tried.
The device was used at home by eight patients, six of whom were
children; it was also used in the Unit for 14 months. Flexibility of
the timing system was used to find optimum timing to get max-
imum clearance. The device will be demonstrated and results pre-
sented and compared with the standard dialysis clearance.
Dialysis, ultrafiltration, and blood pressure. J. Bergstrom, H.
Asaba, P. Fflrsi and R. OulOs. Department of Nephrologv, S:t Eriks
,cjukhus, Siockhol,n, Sweden. Ultrafiltration of overhydrated
patients is often hampered by hypotension, assumed to be caused
by hypovolemia; however, changes in osmolality are also impor-
tant as shown in this study. Six RHD patients with problems of
overhydration were studied during I) single-pass dialysis, Gambro
1.5 m2, 3 hr; II) ultrafiltration only (as in I. except that the fluid
bypassed the dialyzer): III) recirculation dialysis (75 liters) RP, 6 ><
3 hr. During I. ultrafiltration was kept as high as tolerated: during II
and Ill, ultrafiltration was as high as or higher than during I.
Blood pressure, body weight, pulse rate, plasma and dialysate
osmolality, urea, Nat, and protein were recorded. I: All patients
got symptomatic hypotension requiring reduction of negative pres-
sure or iv. fluid. A weight loss of 1.9 kg, a fall in plasma osmolality
of 22 mOsm/kg and a decrease in plasma volume (PV) of 5%
(calculated from . plasma protein) were recorded. II: Blood pres-
sure was unchanged in spite of a weight loss of 3.1 kg and a
decrease in PV of 7%. Plasma osmolality was unchanged. HI.
Blood pressure was unchanged in spite of a weight loss of 3.3 kg
and a 7% contraction of PV. Plasma osmolality fell by 7
mOsm/kg. We conclude that rapid ultrafiltration with hypovo-
lemia does not easily lead to hypotension provided that osmotic
shifts are avoided or minimized. A concomitant rapid change in
plasma osmolality (as occurs in conventional dialysis) interferes
with blood pressure regulation and triggers hypotension.
The type of arterial anastomosis used in renal transplantation and
subsequent complications. M. Bewick, C. S. Ogg. V. Parsons, J. P.
Trafford and M. Goggin. Departments of Surgery and Renal Medi-
cine. Guy's, King's, Royal Sussex County and Canterbury Hospitals,
England. The results of 500 arterial anastomoses were analyzed for
a variety of complications and according to the type of kidney used
in the transplant operation. One hundred fifty-one end-to-end
anastomoses (88 cadaver, 63 live related) are compared with 349
other types of anastomoses. The incidence of hemorrhage was
similar between the cadaver single artery end-to-end anastomosis
(one out of 67) and the live related (LR) (one out of 59). There
were eight incidents of hemorrhage requiring removal of the kid-
ney in 215 cadaver kidney patch grafts (3.72%). With more than
one artery in the cadaver Situation, there were six incidents of
hemorrhage out of 109 grafts (5.5%) and none in the seven LR
grafts however constructed. Thrombosis at the anastomosis was no
commoner with multiple arteries in the cadaver situation, 1.83% of
109 than among the single arteries, 1.92% of 312 compared with
2.78% of 72 LR grafts. Nonfunction at three months was no
commoner using multiple arteries with or without patches, 25.69%
of 109, than in single arteries, 23.72% of 312 operations. Even in
the LR situation nonfunction was equally spread between single
arteries, 11.1% of 72, and multiple arteries, 14.3% of seven. Renal
artery stenosis occurred near]y ten times more frequently with end-
to-end anastomoses (5.13% of 117) than with other methods of
anastomosis (0.53% of 189).
Treatment of ascitis during regular dialysis treatment with in-
traperitoneal colloidal CrP32O4. J. Botella, J. A. Traver and D. Sanz
Guajardo. Clinica Puerta de Hierro, Madrid, Spain. Patients in
RDT may present ascitis of poor prognosis that is generally con-
sidered to be secondary to a chronic, nonspecific, inflammation of
the peritoneum. For this reason, we have administered an isotope
intraperitoneally that has been used successfully in the treatment of
others types of ascitis secondary to nonspecific peritoneal in-
flammation. The patient, a binephrectomized male, developed as-
citis at the 26th month of RDT (3 months of DP and 23 months of
I-ID). The composition of the ascitis fluid was similar to that of
blood plasma and there was no evidence of pericarditis, cardiac
insufficiency, liver disease, abdominal tumor or peritoneal in-
fections. During a period of 12 months, the patient was treated
with ultrafiltration, a high protein diet and human albumin. How-
ever, only a minimum reduction of corporeal weight was achieved.
Because of the lack of success with this treatment, 30 mCi of
colloidal CrP32O4 was administered intraperitoneally in two doses
of 15 mCi each. Within a few days the ascitis disappeared and the
patient continues in this situation, six months after the administra-
tion of the isotope.
Evidence that Ia(OH)-vitamin D3 is converted to I,25(OH)2-
vitamin D3 before acting in normal and uremic man. A. S. Brickman,
J. W. Coburn, G. S. Friedman, S. G. Massry, W. H. Okamura and
A. W. Norman. VA Wadsworth Hospital, U.S.C. and University of
California, Los Angeles and Riverside, California. Disagreement
exists whether lo(OH)-vitamin D (la(OH)D3) is 25-hydroxylated
to l,25(OH)2D5 before acting in D-deflcient animals. Because of
therapeutic implications in man, the dose-response to l,25(OH)2D3
and la(OH)D were characterized from 113 studies in uremic (U)
and normal man (N). Intestinal 'Ca absorption (IACa) and urine
Ca were studied before and after seven to ten days of treatment
(R) with either sterol, 0.14 to 5.4 pg/day. Also, IACa was meas-
ured serially in 12 U patients treated for three to seven months. At
doses <1.0 pg/day, l,25(OH)2D3 was much more potent than
la(OU)D3; with >2.0 pg/day, potency was equal: thus, the dose-
response to lcs-(OH)D3 was steeper. In N, an increase and decrease
in urinary Ca on starting and ending R reflects appearance and
dissipation of sterol action. With la(OH)D3, maximal action was
delayed, and the t½ of dissipation of action was longer, 2.2 + 0.24
vs. 1.5 0.15 days after stopping la(OH )2D3 and 1 ,25-(OH )2D3,
respectively. With long-term R, IACa increased progressively
with l(OH)D3 but was stable with l,25(OH)2D3. The differences
between ls(OH)D and l.25(OU)2D are best explained by need
for 25-hydroxylation of la(Ol-I)D3 before a biologic effect occurs.
At low doses, la(OH)D3 competes with naturally occurring D3 for
the enzyme. With longer R or higher doses, Ia(OH)D3 may
accumulate and then be hydroxylated with continued production
and higher levels of I,25(OH)2D3. Thus, greater danger of D-
intoxication may exist with prolonged R, with la(OH)D3 than
with l,25(OH)2D3.
Plasma lipid abnormalities in children receiving chronic hemo-
dialysis (CHD): Correlations with dietary intake. M. Broyer,
M. J. Tete and M. H. Laudat. Hbpital Enfants Malades, Paris,
France. Frequency and severity of plasma lipid abnormalities in
children on CHD and their relationship with dietary intake were
studied. Seventeen patients, aged 4 to 15 yr. were investigated.
Each consumed a prescribed diet providing 50 to 85 Kcal/kg of
body wt as 58% carbohydrate (CH) and 35% lipid. A single blood
sample was drawn from each patient prior to a dialysis, following a
ten-hour fast. Cholesterol (C), triglycerides (TG) and lipoproteins
were assayed. A careful dietary survey was performed. Sixteen of
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17 children exhibited plasma lipid abnormalities with an increase
in TG: iii = 274 mg/l00 ml (range, 131 to 492) (normal, 80 + 30)
and the presence of pre-beta lipoproteins (PBL), 1112+. Six of 17
patients exhibited an increase in C: ii = 276 mg/l00 ml (range 206
to 375) (normal, 80 10). There was a significant correlation
between TG and calorie intake (r = 0.56, P = 0.01) as well as CH
intake (r = 0.78, P < 0.01). A significant correlation was also
noted between the level of PBL and CH intake (r = 0.66, P < 0.01)
and with saccharose intake (r = 0.68, P < 0.01). Finally, a signifi-
cant correlation was found between C and calorie intake (r = 0.62,
P < 0.02) and lipid intake (r = 0.54, P < 0.05). Other relationships
were established between plasma lipids and clinical parameters:
TG and residual urinary output (r = —0.56, P < 0.02) PBL and
postdialysis BUN (r = 0.59, P < 0.01); C and predialysis creatinine
(r = 0.59, P < 0.01). In conclusion, plasma lipid abnormalities are
frequent in children on CHD. These findings should be considered
when planning the dietary therapy of these patients.
Outcome of renal retransplantation. G. Claes, A. Gusiafsson and
M. Heideman. Department of Surgery, Sahigren 's Hospital, Göte-
borg, Sweden. During 1965 to 1975, 186 retransplantations were
performed on 148 patients. The significance of age, sex, original
disease, 1-ILA matching, presence of cytotoxic antibodies, interval
between rejection and retransplantation and correlation of graft
survival time in primary and retransplanted kidneys was studied in
patients undergoing retransplantation. Results: No difference oc-
curred in the overall results of first and following transplantations.
Better results were obtained with identical compared to noniden-
tical kidneys and when retransplantation was performed in
patients without the presence of cytotoxic antibodies. The most
significant factor determining the fate of a retransplant was the
survival time of the primary graft. In 70 patients who lost their
primary kidney within three months, one-year survival of the sec-
ond graft was 33% compared to 67% in 36 patients with function of
the first graft for more than one year. Conclusion: The individual
capacity of the recipients to react immunologically, i.e., to develop
cytotoxic antibodies and to rapidly reject the primary kidney,
seems to be of crucial importance for the outcome of retransplan-
tation.
Treatment of hemodialysis patients with 1-alpha-hydrox-
ycholecalciferol. E. Clausen, B. Krtólner, B. Lund, F. Melsen, S.
Pars Nielsen, 0. Schaadt and 0. Helmer Sqirensen. Medical De-
partment M (Division of Nephrology) and E and Department of
Clinical Physiology, Frederiksberg Hospital, Copenhagen; and In-
stitute of Pathology, Arhus, Denmark. Seven adult hemodialysis
patients were treated with 1-alpha-hydroxycholecalciferol (I-al-
pha-OH-D3). The patients had signs of varying degrees of sub-
normal bone mineralization and PTH hyperactivity by bone histo-
morphometry. Four of them had elevated serum iPTH levels and
subnormal serum ionized calcium ([Caj). Oral treatment for
three months with 0.5 to 1.5 tg of l-alpha-OH-D3 daily signifi-
cantly ameliorated the histological bone changes and reduced se-
rum iPTH concentration in the four patients with signs of sub-
normal bone mineralization and secondary hyperparathyroidism.
Periodic elevation of [Ca] was induced in all patients. The
elevation quickly subsided by withdrawal of the drug and sub-
sequent treatment with smaller doses. Hypercalcemia was partic-
ularly easy to induce when the patients had no signs of severe bone
lesions. Serum levels of 25-OH-D3 were high in all patients and
were not influenced by the treatment. It is suggested that I-alpha-
OH-D3 treatment of patients with renal disease should be guided
by frequent measurements of the serum levels of [Ca + J and iPTH.
In our opinion it may be too risky to treat hemodialysis patients
without secondary hyperparathyroidism.
Opportunist lung infections in renal transplant patients. W. 4.
Crosbie, V. Parsons and M. Be wick. Renal and Chest Units, King's
College Hospital, London, England. Immunosuppression of renal
transplant patients makes their lungs unduly vulnerable to in-
vasion by opportunist organisms. Unfortunately the resultant ill-
ness is often fatal because identification of the specific invading
organism can be difficult using routine methods. Examination of
the sputum and blood, bronchoscopy and needle biopsy of the lung
are frequently unhelpful. Since specific treatment of the condition
depends upon identification of the causal organism and the patient
rapidly develops respiratory distress, urgent open lung biopsy may
be necessary. We will describe II such patients who developed
severe respiratory illness following an acute rejection episode.
Breathlessness followed by fever, malaise, then lung infiltration
formed the syndrome. We subsequently found the cause to be
bacterial (Mycobacterium tuberculosis), fungal (Candida albicans),
viral (cytomegalovirus), protozoal (Toxoplasma gonaddii, Pneu-
mocystis carinii) and nemetodes (Strongyloides). Despite the use of
appropriate drugs and intensive care facilities, five of the patients
died in the initial illness. Autopsy showed severe lung damage to be
present. In retrospect there was delay in identification of the causal
organism. A more aggressive approach with early lung biopsy is
now advocated in immunosuppressed patients who develop
breathlessness with lung infiltration following a rejection episode.
The renin-angiotensin system in anephric man. J. Deheneffe, V.
Cuesta, J. D. Briggs, J. J. Brown, A. F. Lever, i. J. Morton, J. I. S.
Robertson, P. F. Semple and M. Tree. MRC Blood Pressure Unit
and Renal Unit, Western Infirmary, Glasgow. Scotland. Four female
and three male anephric subjects were studied at intervals ranging
from IS days to five years after nephrectomy. Plasma renin sub-
strate levels were normal except in one female receiving oral con-
traceptives (significant elevation). Significant levels of plasma renin
concentration (PRC) and plasma angiotensin II concentration (P
All C) were detected in all cases and were within the normal range
in most. There was a significant relationship (P < 0.05) between
simultaneously measured PRC and P All C. Both Sephadex G-15
and paper chromatographies of the radioimmunologically detected
All showed no difference between anephric and normal subjects.
Na depletion, achieved by dietary Na restriction and weight-reduc-
ing hemodialysis, did not significantly alter PRC or P All C.
Moreover, one H. hypertonic saline infusion (3 mEq/kg) com-
bined with All infusion (I ng X kg-' )< min') did not suppress
PRC. All metabolic clearance rate was calculated during All
infusions and found to range from 22 to 52 ml X kg-' >< min'; it
was not significantly altered by Na depletion. The data suggest the
existence of a functional although physiologically abnormal renin-
anglotensin system in chronically nephrectomized human subjects.
Cardiac interaction of parathyroid hormone (PTH) and prop-
ranolol in uremia. 7'. Drfieke, F. Lhoste, S. Larno, J. Zingraff N. K.
Man, P. Jungers, J. R. Boissier and J. Crosnier. Hbpital Necker,
Paris. France. Ultrafiltrates of uremic plasma (UFs) have been
sampled in eight severely hyperparathyroid (prePTx) patients on
chronic hemodialysis and in eight subtotally parathyroidectomized(postPTx) patients; 0.5 ml of UF was added to 25 ml of incubation
medium bathing isolated guinea pig auricles. The depressant effect
of 1.35 X l0 M d-l-propranolol on myocardial contractile force
at five minutes (—25.8% + 2.6 SEM of normal) was significantly
inhibited by UFs of all the prePTx plasmas (—16.4% 0.6, P <
0.001). No such inhibition was found with six of seven UFs from
postPTx subjects. A direct effect of bovine PTH (bPTH) was
sought by adding synthetic l-34-bPTH (Beckman) to the incubate
in concentrations of 0.4, 1.2, 4.0 and 40.0 ng/ml. The depressant
activity of 1.35 X l0- st d-l-propranolol on myocardial con-
tractile force at five minutes was significantly (P < 0.02) inhibited
in the presence of bPTH concentrations of 1.2 ng/ml or more. No
such inhibition was observed in the presence of 0.4 ng/ml of bPTH
alone. Conclusion: PTH decreases the cardiac responsiveness to the
beta-adrenergic blocking agent propranolol. This interference
could be of clinical importance in uremic patients with hyperpar-
athyroidism.
Studies of cellular immune responses in patients with minimal
change nephropathy. K. Eyres, N. P. Mallick and G. Taylor. Man-
chester Royal Infirmary, Manchester. England. Evidence for cell-
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mediated immunity to kidney antigens has been reported pre-
viously in association with a number of patterns of glomerular
damage using the leucocyte migration test (LMT). We have stud-
ied particularly patients with minimal change nephropathy and
present further evidence of cellular immune responses in this con-
dition. In addition to using the leucocyte migration test, we have
assessed CMI by lymphocyte toxicity to a cell culture derived from
trypsinized human kidney. Nine of 12 patients studied showed
lymphocyte toxicity to the kidney cell culture in which the target
cells were predominantly of epithelial origin and may derive from
the renal tubules. Two antigen preparations were used in the LMT.
One was prepared from homogenized human neonatal kidney;
immunochemical analysis suggests that this preparation is largely
tubular in composition. The other antigen was GBM preparation
derived from separated glomeruli of adult human kidney. Six of
ten patients had a positive LMT using the GBM antigen and nine
of ten had a positive LMT to the neonatal kidney antigen, as did a
total of 2 1/29 patients in whom this antigen was used. A serum
factor which blocked the LMT was present in all these 21 patients.
Sequential studies were performed over two years and seven re-
lapses were monitored. During steroid therapy the LMT became
negative temporarily. In one patient who received a prolonged
course of cyclophosphamide, the LMT became negative and has
remained so.
Formaldehyde and the occurrence of anti-N-like cold agglutinins in
RDT patients. W. Fassbinder, J. Pilar, E. Scheuermann and K. M.
Koch. Department of Nephrology, University of Frankfurt/Main,
Germany. Recent reports describe a high incidence of cold aggluti-
nins with preference to N (anti-N-like antibodies) in RDT patients.
The purpose of the present study was to determine whether the
incidence of this antibody is affected by dialysis technique. Aggluti-
nation tests were performed in 270 RDT patients. In 60 anti-N-like
agglutinins were present. None of 74 patients treated with non-
reused gas- or X-ray-sterilized dialyzers was positive. Ten of 36
(28%) patients with single-use and 50 of 160 (3 1%) with reuse of
formaldehyde-sterilized dialyzers were positive. The difference be-
tween the groups using formaldehyde is not significant. In in vitro
studies MM-cells, originally not agglutinated, reacted after in-
cubation with 0.4 to 0.1% formaldehyde with anti-N-like antibody;
formaldehyde-treated NN-cells reacted stronger than untreated
NN-cells. Agglutination of both cells by commercially available
anti-N and anti-M was not altered. in vivo action of anti-N-like
antibody was proven by shorter survival of transfused NN-cells
when compared with own (MN) red blood cell survival in two
antibody-positive patients. The results indicate that formaldehyde
is a causative factor in the genesis of anti-N-like cold agglutinin.
The corresponding antigen appears to be a derivate of the MN-
system developing after contact with formaldehyde in vitro and
presumably in vivo,
Aluminum intoxication: The cause of dialysis dementia? J. A.
Flendrig, H. Kruis and H. A. Das. Department of internal Medecine.
Catharinaziekenhuis, Eindhoven, Holland; and R. C. N. Petlen,
Holland. The fatal disease syndrome of dialysis dementia occurs in
a few dialysis centers, in different parts of the world. In our
hospital the syndrome developed in six patients, after two to four
years of dialysis. The concentration of aluminum in the dialysate
was 15 times higher than that in the tap water. This aluminum was
brought into the dialysate by water, which was heated in a boiler,
containing two aluminum amodes as part of a cathodic protection
system. Aluminum contents were determined, by means of neutron
activation analysis, in tissues 1) ofnormal patients, 2) of patients
who had died of chronic renal insufficiency, 3) ofpatients dialyzed
in other Dutch centers who died without dialysis dementia, 4) of
patients who died of dialysis dementia. The concentration of
aluminum in the liver, spleen, bone and brain of the patients with
dialysis dementia was significantly higher than that in the tissues of
the other three categories of patients. Thus, our results were in
agreement with the recently published findings of Alirey et al.
However, we do not agree with his supposition that aluminum
containing phosphate-binding gels can be the cause of the alumi-
num storage in dialysis dementia. This last statement will be dis-
cussed.
Decreased drug conjugation as a pathogenic factor in the etiology
of analgesic nephropathy. K. I. Furman, G. F. T. Galasko and C. S.
Block. Johannesburg Hospital and Universtiy of the Witwatersrand,
Johannesburg, South Africa. Following ingestion of phenacetin or
paracetamol, N-acetyl-para-aminophenol (NAPA) is excreted in
the urine mostly as conjugates of glucuronic and sulphuric acids.
Being less lipid-soluble, these conjugates do not diffuse back across
the tubular epithelium to the interstitum of the kidney. They are
eliminated rapidly and are therefore less liable to be toxic than free
NAPA. In 50 normal subjects the ratio of unconjugated to con-
jugated NAPA present in urine 12 hr after a standard I g dose of
paracetamol was variable but mostly less than 0.15. In 20 patients
suffering from established analgesic nephropathy tested in the
same manner, the ratio was generally greater, often being as high
as 0.50. In three patients suffering from active Escherichia coli
urinary tract infections, the same ratio was noted to fall after the
infection was controlled by antibiotics. The organisms cultured
were shown to have in vitro glucuronidase activity. The results of
this study suggest that impaired hepatic drug conjugating ability
may be a factor in the etiology of analgesic nephropathy, and that
bacterial deconjugating enzymes produced during the course of
urinary tract infections may play an additional role.
Kidney transplantation as the method of choice for treatment of
chronic renal failure. L. E. Gelin. Department of Surgery. Sahlgren's
Hospital, Giteborg, Sweden. To satisfy the total demand of active
treatment for terminal renal failure, a program was built in Goth-
enburg with renal transplantation as the only method for definite
treatment, partly because of lack of dialysis facilities, partly be-
cause of economical reasons and partly because of the belief that
renal transplantation is the only definite way of treatment. A donor
organization with all neighbor hospitals was set up to procure a
sufficient number of acceptable donor organs. The recipients were
accepted liberally without age limit. Seven hundred five trans-
plantations have been performed during the decade 1965 to 1975.
The donor source was 105 living donors and 600 cadaveric donors.
Because of graft failure, 191 retransplantations were perforrtied in
149 patients as soon as possible. The eost benefit analysis and
rehabilitation grading of the recipients have been determined. Con-
clusion: With kidney transplantation as the main method for treat-
ment of terminal renal failure, the total care of this otherwise lethal
condition can be quantitatively solved for the population with
reasonable economical and manpower input.
The site of sodium retention in glomerulonephritis: Role of a
natriuretic factor of renal origin. J. P. Godon. Instilut de Mëdecine.
Université de Liege, Liege Belgium. In previous work, we have
demonstrated that rats with experimental glomerulonephritis
(GN) were unable to increase fractional and absolute sodium
excretion after saline loading. This inability is not due to changes
in blood dilution factors such as plasma oneotic pressure but
rather to the disappearance of a natriuretic material that we have
shown to be of renal origin. Analogous results were obtained in
human GN. In order to identify the nephronic site of the enhanced
tubular sodium reabsorption, two techniques were used: I) study
of TmG in normal and glomerulonephritic rats during a progres-
sive saline load: 2) mieropuncture studies of sodium and water
reabsorption. The results clearly demonstrate the following: I)
In GN rats, Tmti is increased in proportion with Na reabsorption.
2) TmG decreases, of the same magnitude, in GN and normal rats
during progressive saline loading. 3) The site of the increased
sodium and water reabsorption is proximal as evidenced by glu-
cose titration curve and micropuncture studies. 4) There is a dis-
ruption of glomerulotubular balance in GN rats. Moreover, the
parallel behavior of TmG and proximal Na reabsorption, both
before and after Na loading, strongly suggests that the part of
sodium transport presumably linked to glucose transport is selec-
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tively involved. These results also suggest that the observed dis-
orders are due to the disappearance of a renal natriuretic factor,
the site of action of which is presumably proximal.
Middle molecules and hemoglobin synthesis. G. Goubeaud, H. W.
Leber, H. H. Schott and G. Schütterle. Zenlrum f Innere Medizin,
Giessen, West Germany. A new method for isolating middle mo-
lecular substances from uremic fluids and normal urine using ultra-
filtration and Sephadex Gl5-gelfiltration with a double-column
system is described. Using this separation method, two peptide-
containing fractions with a molecular weight between 1000 and
1400 daltons were isolated from uremic serum, dialysate and urine.
These fractions were not present in normal serum. Thin-layer
chromatography revealed that most of the isolated fractions con-
sisted of several components. The middle molecular fractions from
uremic fluids and urine were shown to influence two important
steps toward hemoglobin synthesis (porphobilinogen and globin
synthesis), when added to the assay systems in vitro, but they
altered neither porphyrin synthesis nor ATPase activity in red
blood cells. Our results support the assumption that middle mo-
lecular solutes may be important as uremic toxins, especially with
regard to uremic anemia.
The effect of renal transplantation on a home dialysis program. J.
Hawkins, B. Mahood, R. Naik and B. H. B. Robinson. East Bir-
mingham Hospital, Birmingham, England. One hundred patients
have been maintained on home dialysis for periods of one to ten
years. Fifty-six have asked to be considered for transplantation. Of
these, 38 have received cadaveric and I a live donor transplant. Six
patients have received a second transplant. Nineteen patients are
alive with well-functioning grafts. Fourteen patients died as a
direct consequence of transplantation. Survivors with graft failure
returned to home dialysis. Seventeen patients on home dialysis
who had not received transplants or who had returned to dialysis
after graft failure have died over the ten year period. Fifty percent
of transplant deaths were attributable to infection and only two
each to cardiac or cerebrovascular causes. In contrast 9/17 deaths
on home dialysis were due to cardiac disease, 4/17 to strokes and
only one to infection. Despite close histocompatibility matching
and ready availability of a return to dialysis in the event of graft
failure, transplantation seriously decreased the survival of home
dialysis patients. The choice would seem to pose an ethical di-
lemma, yet a majority of home dialysis patients, fully aware of the
hazards, opt for the hope of an improved quality of life.
Plasma immunoreactive calcitonin and bone disease in dialyzed
patients. G. Heynen. J. A. Kanis, M. Earnshaw, C. G. Woods, D. 0.
Oliver, J. G. G. Ledingham, R. J. Walton and R. G. G. Russell.
Department of Medicine, University of Liege, Renal Unit, Churchill
Hospital and Nuffield Orthopaedic Centre, Oxford, England. Pre-
vious studies have shown that dialyzed patients may have increased
serum levels of immunoreactive calcitonin (iCT). We have related
these observations to several indices of skeletal metabolism in 55
patients on hemodialysis. Two groups of patients could be identi-
fled on the basis of their plasma alkaline phosphatase (AP) values,
which showed a bimodal distribution. The group with the high
levels of AP had significantly higher levels of immunoreactive
parathyroid hormone (iPTH) and lower levels of iCT than the
remaining group with normal activities of AP. There was no differ-
ence in mean plasma phosphate between the groups. Twenty-seven
patients established on dialysis showed little spontaneous variation
in 'PTH and iCT when sequential studies were made over several
months. Histological data from transiliac bone biopsies in 28
patients showed that there was an inverse correlation between iCT
and the degree of bone turnover as measured quantitatively by
active osteoclastic and active osteoblastic surfaces and the degree
of bone mineralization (calcification front). These results suggest
that the secretion of endogenous CT may protect against increased
rates of bone turnover in dialyzed patients.
1-Alpha-hydroxycholecalciferol in the treatment of renal os-
teodystrophy. B. J. R. Junor. G. R. D. Catto and M. MacLeod.
Department of Medicine, University of Aberdeen, United Kingdom.
Eleven patients with osteodystrophy due to renal failure, eight of
whom required hemodialysis, were treated with 0.5 to 3 .sg/day of
1-aipha-hydroxycholecalciferol (l-a-OHCC) for one year. The ef-
fect of therapy was assessed by radiographic skeletal survey, bone
mineral analysis, neutron activation analysis, biochemical changes
and serial biopsy of bone. All patients with predominant Os-
teomalacia on initial bone biopsy showed improvement in sub-
sequent biopsies, accompanied by a fall in serum alkaline phospha-
tase level. Two patients with predominant hyperparathyroidism
showed no improvement on subsequent biopsy at six months and
the serum alkaline phosphatase remained elevated. One developed
symptomatic hypercalcemia which persisted despite withdrawal of
1-cs-OHCC therapy. The parathormone level at this time was
greater than 10 ng/ml and at parathyroid exploration, four grossly
enlarged adenomatous glands were removed. The second patient
with predominant hyperparathyroid changes showed in the initial
six months of treatment suppression of a previously markedly
elevated parathormone level. Following an increase in dosage of I-
a-OHCC, serum alkaline phosphatase fell to within normal limits
and radiological abnormalities disappeared. It is concluded that I-
a-OHCC is an effective means of treating both the osteomalacia
and hyperparathyroid changes of renal osteodystrophy provided
that tertiary hyperparathyroidism has not occurred.
Changes in skeletal homeostasis after bilateral nephrectomy in
dialyzed patients. J. A. Kanis. M. Earnshaw, G. Heynen, D. Oliver,
C. Price, C. G. Woods and J. G. G. Ledingham. Renal Unit and
Nuffield Orthopaedic Centre, Oxford, England. The endocrine func-
tions of the kidney include degradation of parathyroid hormone
and calcitonin and the production of 1:25 dihydroxycholecalcife-
rol. It is surprising that previous studies have not shown bine-
phrectomy to be associated with consequent changes in bone histol-
ogy or the activity of plasma alkaline phosphatase. We have
studied 27 dialyzed patients who underwent binephrectomy prior
to transplantation. Quantitative histology of bone, plasma alkaline
phosphatase, hydroxproline, calcium, ,hosphate and immunoreac-
tive parathyroid hormone and calcitonin were measured at stan-
dard times relative to dialysis. Binephrectomy was followed by rapid
and sustained falls in plasma bone-derived alkaline phosphatase, if
these were previously elevated. There were associated histological
changes with reductions in osteoblastic activity, calcification front
and bone fibrosis. Plasma phosphate fell, and plasma immunoreac-
tive calcitonin rose after oephrectomy whereas no changes were
detected in plasma calcium or immunoreactive parathyroid hor-
mone. These findings suggest that the kidneys of patients with end-
stage renal failure still contribute to skeletal homeostasis in a way
hitherto unsuspected, perhaps by regulating the rate at which
calcitonin is degraded or secreted.
The effects of uremic compounds on oxygen consumption and
mechanical activity of isolated guinea pig hearts. Friedrich Kersting
and Horst Brass. II. Med. Abt. des Klinikums der R WTH. Aachen,
Federal Republic of Germany. Cardiac function has been reported
to be altered in uremia. The effects of urea, creatinine and guani-
dinosuccinic acid (GSA) on dynamic performance and oxygen
consumption (Q02) were studied in isolated hearts of normal
guinea pigs. The hearts were perfused isovolumetrically (10
mI/mm) with tyrode solution and stimulated constantly with 2.5
Hz. Cumulative dose-response curves were followed by application
of noradrenaline (NA). In the dose range used, none of the three
compounds caused a significant change in maximum left ventricu-
lar dP/dt or in Q02. NA alone exerted a substantial positive
inotropic effect which was accompanied by a marked increase in
QO. This response was not changed after pretreatment with
creatinine and GSA. However, after urea perfusion, the effects of 1
>< 10 g/ml of NA on dP/dt and Q02 were significantly dimin-
ished. In addition, the ratio of dP/dt over QO2 had become smaller
after urea administration, thus indicating a lesser degree of eco-
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nomic heart performance. Possible mechanisms of urea on myo-
cardial membrane and/or metabolism are discussed.
Lymphocyte enzymes of DNA-synthesis in chronic renal failure.
R. Korz, U. Loebnitz, H. Brunner and R. Heintz. Department of
internal Medicine ii, Technical University of A achen, Federal Re-
public of Germany. Addition of uremic serum to lymphocyte cul-
tures induces restriction of DNA synthesis as well as impaired cell
viability. The latter effect may be due to retained higher molecular
metabolites traceable in urine from healthy persons causing dose-
dependant depression of transformation by accelerated cell de-
struction. Investigations of the intracellular enzymes thymidine
kinase and DNA polymerase were performed after one-hour in-
cubation of normal lymphocytes in serum from patients with regu-
lar dialysis treatment and in increasing quantities of lyophilized,
not dialyzable residue of urine from healthy persons obtained by
four days' dialyzing against water. Uremic serum induces a signifi-
cant decrease of thymidine kinase corresponding with depressed
spontaneous lymphocyte transformation: DNA polymerase re-
mained unaltered. Higher molecular urine metabolites showed no
influence on both enzymes. Therefore, depressed enzymatic DNA
synethesis is discussed as the main reason of disturbed cellular
immunity in chronic uremia; a separate cytotoxic effect may be due
to retained higher molecular toxins.
Effect of 3H-uridine (iHU) incorporation in human uremic plasma
by prostaglandin (PGA2). J. Levi, H. Bessler and M. Djaldeiti.
Departments of Medicine "B" and Nephrology, Hasharon Hospital,
Petah- Tiqvah, Tel-A viv University Medical School, Israel. The
study was carried out to investigate the effect of PGA2 on 3HU
uptake in erythroblast incubated with plasma from uremic
patients. Previous experiments have demonstrated that eryth-
ropoietin stimulates RNA synthesis in cultured 12-day fetal mouse
liver proerythroblasts as measured by 3HU incorporation. Twelve-
day embryonic mouse liver erythroblasts were incubated with nor-
mal and uremic human plasma in the presence and absence of 10
gg of PGA2 for three hours. To all samples 5 .iCi of 3HU was
added for 30 mm. Erythroblasts incubated with PGA2 showed a
dose-dependent increase of the 3H U uptake. The addition of PGA2
to erythroblasts incubated with normal or uremic plasma caused a
30 to 60% increase in 31-lU incorporation as compared to cells
incubated '.ithout PGA2. The results indicate that PGA2 has a
possible erythropoietin-like effect, which could be applied for stim-
ulation of RNA synthesis and even erythropoiesis in uremic
patients.
Clinical application of a sorbent-based peritoneal dialysate regene-
ration system. Andrew J. Lewin, Arthur Gordon, Michael Blu-
menkrantz, Joselyn Bailey and Morton H. Maxwell. Cedars-Sinai
Medical Center, VA Wadsworth Hospital Center, Department of
Medicine, UCLA School of Medicine, Los A ngeles, California. A
low volume sorbent-based dialysate regeneration system for use in
peritoneal dialysis (PD) has been developed based on similar prin-
ciples as sorbent regeneration of hemodialysate. After assuring the
maintenance of sterile, particulate-free peritoneal dialysate in ani-
mal experimentation, we have performed up to ten hours of contin-
uous peritoneal dialysis encompassing IS exchanges in chronically
uremic patients. The sorbent cartridge renders the peritoneal dialy-
sate free of urea, creatinine, K and P04, and Ca and Mg concentra-
tions are maintained by an infusion system. The clearances for urea
and creatinine are 20 to 24 and 12 to 16 mI/mm, respectively.
These clearances are similar to those found with conventional
intermittent PD. The pre-eartridge dialysate concentration of NA
and Cl decreases because of dilution with hyponatric ultrafiltrate.
Contribution of these ions to the dialysate by the sorbents enables
their concentration to be maintained at a stable level. Dialysate
glucose concentration is maintained by the addition of a concen-
trated glucose solution via the infusion system. Stringent tests for
bacterial contamination have proved the system sterile and these
early clinical studies indicate the feasibility of conducting an
entire PD with 6 liters of dialysate. In the future, similar concepts
should lead to the development of an ambulatory peritoneal
dialysis unit.
Permanent withdrawal of prednisone in necro kidney trans-
plantation. Hans Løkkegaard and J. Hess Thaysen, Med. Dept. P.,
Rigshospitalei, Copenhagen, Denmark. In the period from Decem-
ber, 1968 to January, 1974, a total of 192 first necro kidney trans-
plantations were carried Out. Two years after transplantation, 75
grafts still functioned on conventional treatment with azathioprine
and prednisone, the latter in an average dosage of 12.5 mg/day.
During the following 3'/2 to 5 yr, prednisone dosage has been
gradually reduced below 12.5 mg/day and has been completely
withdrawn in 21 patients. Two patients on no prednisone showed
evidence of acute rejection following withdrawal, but the rejection
episodes were reversible on resumption of steroid treatment. In the
remaining 19 patients, graft function remained normal despite
withdrawal of prednisone during an average observation period of
II months (range, 3 to 27). The preliminary results indicate that
prednisone may be completely withdrawn about 3½ to 5 yr after
grafting without apparent risk and with good results in the major-
ity of the cases.
The charcoal capillary hemoperfusion system. P. 5. Malchesky, R.
Nokoff and Y. Nose. Department of Artificial Organs, Cleveland
Clinic, Cleveland, Ohio. Sorbent hemoperfusion has been shown to
be effective in toxin removal; however, its application has been
plagued with problems of blood incompatibility and sorbent car-
ryover into the vascular system. Utilizing hollow fibers made of
Cuprophan containing activated charcoal (Enka Glantzstoff), par-
ticle release can be prevented while maintaining good blood com-
patibility. The fiber is incorporated into devices of rectangular
design which evenly distribute the flow. Units were evaluated in
vitro at a simulated blood solution flow of 200 mI/mm recirculated
from a bath of 34 liters for four hours. A three-modular system of
0.71 m2 membrane surface area containing 77 g of charcoal (C) had
mean uric acid and creatinine clearances of 140 and 107 mI/mm.
1.6 g of uric acid (63% reduction, 21 mg/g of C) and 1.5 g of creatinine
(53% reduction, 20 mg/g of C) were removed. Particle release as meas-
ured by the weight increase in a O.22M Millipore filter after per-
fusing 35 bed volumes of sterile saline is less than 1 mg and similar
to the control. Perfusion studies on calves have been tolerated well.
In a two-hour study, serum electrolytes, enzymes and chemistries
were unchanged. 1-leniatologic indexes were stable with the ex-
ception of platelet count which dropped 50% and rebounded two
days later and fibrinogen which dropped 30% in the first hour and
rebounded by the end of the perfusion. Utilizing this system,
removal of low molecular weight solutes can be effectively
achieved. With the same basic design, fibers containing other sor-
bents can be employed with simultaneous dialyses in a single
device.
Long-term experience of home dialysis with sorbent regeneration
of dialysate. M. A. Mansell and A. J. Wing, Si. Thomas' Hospital
London, England. Eleven patients have been treated for periods up
to 20 months by home hemodialysis using sorbent and ion ex-
change regeneration of dialysate (SRD, "Redy" system). They
were selected from 45 patients either because a conventional single-
pass system (SPS) would have required expensive adaptations or
rehousing of the patient and family, or because early trans-
plantation was planned. Biochemistry in SRD and SPS patients
was compared. Patients on SRD had higher urea and creatinine
levels (+l2%) attributable to lower dialysate flow rates. With
initial prime containing 35 mmoles of acetate, SRD patients devel-
oped hyperchloremie acidosis and studies on their leucocytes dem-
onstrated intracellular potassium depletion. Increasing acetate
concentration of the prime restored normal acid-base status and
corrected intracellular potassium. To date there is no biochemical,
radiological or histological evidence that the development of the
osteodystrophy has accelerated. Home dialysis using SRD is flex-
ible, independent of housing conditions and provides more free-
dom for the patients. Higher revenue costs are offset by economies
in home adaptations and hospital dialysis.
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Angiotensin blockade as a rapid diagnostic test in hypertension. L.
S. Marks, M. H. Maxwell, U. Waks and J. J. Kaufman. UCLA
Medical Center, Los Angeles, California. Saralasin, l-sar-8-ala-
angiotensin 11, a specific competitive inhibitor of angiotensin, was
administered to patients in a controlled, prospective study de-
signed to test the hypothesis that this agent is a useful tool to detect
renin-mediated hypertension. The studies were done before and
after salt depletion. After iv. administration of saralasin (bolus
injection, then sustained infusion), a readily apparent decrease in
blood pressure was observed in 16 of 17 patients with confirmed
renovascular hypertension (RVH) and also in 4 of 27 patients with
essential hypertension (EH). Depressor response to saralasin cor-
related well with elevated renin levels; moreover, depressor respon-
ses were also noted in normoreninemic patients with RVH, but not
EH. Mild salt depletion eliminated falsely negative tests and
caused no falsely positive tests. Depressor responses to saralasin
were associated with large increases in plasma renin activity, but
not with significant changes in plasma aldosterone levels during the
test. In patients with RVH or incidental stenoses, response to
saralasin correlated favorably with operative results. The saralasin
test is completely safe and valid only if the patient is mildly salt-
depleted, not taking other antihypertensive drugs and genuinely
hypertensive at the time of the test.
Effect of renal transplantation on uremic deafness. H. Mitschke,
P. Schmidt, J. Zazgornik, H. Kopsa and P. Pils. 1 Department for
Otolaryngology and 1st Department of Internal Medicine, Univer-
sity of Vienna, Austria. Hearing loss is a common finding in
patients with chronic renal failure. Audiometrical controls were
performed before and after renal transplantation in order to in-
vestigate the influence of a functioning transplant on uremic deaf-
ness. Thirteen patients (mean age at transplantation: 38.2 (17 to
54 yr) were studied up to 28.5 (8 to 46) months after surgery.
During RDT there was a marked hearing loss for the higher
frequencies between 2048 and 8192 Hz. Hearing loss was 17.4 +
11.8 dB at 2048 Hz, 16.5 + 13.1 dB at 2896 Hz, 21.2 16.1 dB at
4096 Hz, 30.8 + 15.8dB at 5792 Hz and 29.2 + 21.6 dB at 8192 Hz,
respectively. Hearing capacity improved to normal after trans-
plantation, the optimal audiometrical results being obtained 2l.4
(8 to 42) months after surgery. There was a significant increase in
hearing capacity especially for the middle and high-tone frequen-
cies. The mean increase was 11.5 9.4 dB at 2048 Hz, 11.5 11.8
dB at 2896 Hz, 13.5 + 12.0 dB at 4096 Hz, 21.2 13.9 dB at 5792
Hz and 21.5 + 20.8 dB at 8192 Hz, respectively. The data show that
uremic deafness is reversible after renal transplantation. It is
assumed that uremic toxins, possibly responsible for inner ear
deafness in chronic renal patients, may be sufficiently removed
by a functioning transplant.
Comparative evaluation of iatrogenic sources of blood loss (BL)
during maintenance dialysis (MD). K. Mohring, H. Sinn, H. W.
Schijler, R. Horsch. H. Kriger and H. W. Asbach. Department of
Urology, Surgical Centre and Cancer Research Centre, Heidelberg,
Federal Republic of Germany. The exposure of patients on MD to
technically unavoidable, iatrogenic BL has been a major concern.
In 1974 a new method for labelling red blood cells by "'Indium
was introduced, yielding 20 times higher counting rates and,
hence, accuracy while imposing less radiation than 5'Cr labelling.
Since 1975 this method has been applied to quantify possible
sources of BL during HD in 13 children covering a total of 86
dialyses. Bleeding during access to the vessels, leakage at the
puncture sites and residual blood (RB) in the needle set summed
up to 1.3 ml (range, 0.5 to 6.1 ml). RB in the extracorporeal
blood lines was I ml (0.4 to 1.7) and RB volume in dialyzers
suitable for pediatric patients was comparably low in the Travenol
Hoeltzenbein (2.2 + 1.59; N = 17) and the Lundia 13.5 s
(2.2 1.63; N = 17). The RP5(3.5 + 0.97; N = 6), the CD HFAK
M4 (11.3 + 13.5; N = 17), and the CD HFAK MS (12.9 8.9;
N = 23) showed higher RB volumes, though priming, degassing,
washback technique and heparinization were standardized. BL
arising from laboratory work up, needing 4 ml of plasma, was
reduced to 10% (BL: 0.8 mI/sample) by allowing sedimentation
and reuse of red blood cells. Gastrointestinal hemorrhage measured
before and after treatment with acetylsalicylic acid (ASS) was
substantial in untreated (7.4 6.l 1 mI/day), and increased
markedly after treatment with ASS (22.2 + 15.16 mI/day).
Figures show that avoidable iatrogenic BL may contribute es-
sentially to chronic anemia.
Three-hour maintenance dialysis combined with direct hemoperfu-
sion and hemodialysis. Michio Odaka, Y. Tabata, H. Kobayashi, M.
Soma, Y. Nomura, H. Hirasawa, H. Sato, E. Suenaga and K.
Nabeta, introduced by H. J. Gurland, Department of Surgery (II),
School of Medicine, Chiba University, Chiba and Bio-Medical Re-
search Institute, Te(jin Ltd., Tokyo, Japan. Microencapsulated acti-
vated charcoal absorbs creatinine, uric acid and middle molecular
weight substances, but no urea and water. Coconut broken char-
coal, however, releases fine particles because of its soft hardness.
We have devised a new dialysis system combined with hemoperfu-
sion by an albumin-coated, microencapsulated, bead-shaped acti-
vated carbon and HFK in series and used simultaneously. This
system can remove two to three times the urea, creatinine and uric
acid, compared with a semipermeable membrane. This charcoal
has a spherical form leading easily to micro-encapsulation of its
surface, with better absorbent capacity than coconut charcoal.
This three-hour dialysis system has been used on two patients with
terminal renal failure since August. 1975. These patients have been
kept well with good blood chemical data. During three hours, an
average of 1,892 ml of water was removed (blood flow is on the
average 204 mI/mm). The reduction ratios of urea, creatinine and
uric acid are 43.9, 50.5 and 60.4%. The blood cells are not de-
creased by the dialysis and this system can adjust an acid-base
balance.
Petroleum-based activated charcoal for direct hemoperfusion.
Kazuo Ota, Takashi Ohta. Masami Kobayashi, Satoshi Yoshida,
Iwakazu Kaneko, Tetsuzo Agishi and Masayasu Sugihara. in-
troduced by K. Maeda. Kidney Center and Pharmaceutical Section,
Tokyo Women's Medical College Tokyo, Japan. To shorten dialysis
time or to achieve more efficient removal of uremic toxins, use of
activated charcoal as adsorbent has gained a renewed interest in
recent years. The clinical use of hemoperfusion has been retarded,
however, by several side effects such as platelet adhesion or migra-
tion of fine characoal fragments into the systemic circulation. An
artificially beaded petroleum-based activated charcoal used in this
study has a diameter ranging from 250 to 500 . Its round shape is
suitable for microencapsulation and its hardness prevents release
of fine fragments into the circulation. Charcoal beads are micro-
encapsulated with collodion and albumin and are sterilized by
autoclaving. Animal experiments proved its efficacy as well as
abscence of side effects. Two cases of chronic renal failure and a
case of drug intoxication were successfully treated with hemoperfu-
sion using the microcapsules in combination with conventional
four-hour hemodialysis. Average reduction rate in these cases are
as follows: BUN, 37.0%; creat, 44.3%; and uric acid, 53.2%. As to
phenobarbital intoxication, 2'/2-hr hemoperfusion reduced the
blood level from 10.8 to 7.3 mg/100 ml.
Renal concentration and dilution during acute lithium infusion. M.
Martinez-Maldonado. San Juan VA Hospital and Departments of
Medicine and Physiology, Unioersity of Puerto Rico School of Medi-
cine, San Juan, Puerto Rico. Chronic lithium (Li) administration in
the rat leads to reduced renal concentration (TCH2O) without
alterations in renal dilution (CZo). To examine the acute effects of
Li on TH2O and CR2O, unanesthetized rats were infused with a
solution composed of 1% MaCI and 1% LiCI or a 0.225% LiCI
solution at rates from 0.06 to 0.5 mI/mm. In eight rats, infusion of
Na-Li solution resulted in marked inhibition of TCHZO at any level
of osmolar clearance (Cosm) when compared to animals receiving
2% NaCI alone. Administration of amiloride (AM), 40 or 80
mg/kg/mm throughout the experiment, to nine rats infused with
Na-Li solution resulted in marked improvement of T°H2o to Cosm
relationship. Infusion of 0.225% LiCI to nine rats undergoing water
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diuresis led to marked reductions in C1120 as a function of distal
delivery (V) when compared to rats receiving 0.225% NaCl alone.
Infusion of AM did not improve the Co to V relationship. These
studies suggest that Li interferes with Cl reabsorption in the loop
of Henle and also reduces the permeability of the collecting duct to
water. AM, probably by interfering with Li transport into collect-
ing duct cells, corrects partially the T20 defect by preventing
water permeability changes. The lack of the effect of AM in Cno
studies may relate to the fact that collecting duet permeability is
already at its lowest. It reinforces the suggestion that Li retards
C1 reabsorption in the ascending limb as infered from the TCHZO
studies. Both Cl and Na are required for normal loop function.
Angiotensin II blockade in hypertension of repetitive hemodialysis
patients: Physiological and therapeutic implications. A. Mimra,n, G.
Deschodt, C. Polito, C. Mion, P. Bqrjon and S. Shaldon. Depart-
ments of Medicine 0 and S. T.I.R., C.H. U. Monipellier. France, The
role of angiotensin lI(A 11) in dialysis-resistant hypertension(DR)
has been widely discussed. Saralasin (P 113), a specific and com-
petitive inhibitor of A II, was used to investigate the A lI-volume
interaction in DR patients. p 113 was infused at two dose levels
(0.5 and 2.5 sg/kg/min) for 30 mm in six DR, and five dialysis-
controlled hypertensive patients (DC) and two normotensive bi-
nephrectomized patients (BN). The study was performed four
hours before and one hour after a four-hour hemodialysis (HD).
Before HD, P 113 normalized blood pressure (BP) in three of six
DR patients and significantly reduced BP in two. After HD, BP
was normalized in five DR patients. One DR patient was totally
resistant to P 113, but HD reduced BP from 194/134 to 154/116.
She was considered to be totally volume-dependent. In three of five
DC patients P 113 reduced BP. It had no effect in two BN patients.
Plasma renin activity (PRA) and the P 113 hypotensive effect were
directly correlated (r = —0.66, P < 0.005). The normalization of
BP in DR patients by P 113 suggests that their hypertension was A
11-dependent and thus controllable by a-blockers. We found P 113
to be of no value in predicting the need for binephrectomy. How-
ever, a negative response was valuable in indicating the need for
more vigorous ultrafiltration in BP control.
Deleterious effect of Au antigenemia on long-term survival of
transplanted patients. Y. Pirson, G. P. J. Alexandre and C. van
Ypersele de Strihou. Renal Unit. Cliniques Universitaires St. Pierre,
Louvain, Belgium. The possibility that persistant HBAg+ improves
the one- and two-year graft survival (OS) has been recently raised.
However, the high incidence of late death from hepatic failure
(HF) notedin our HBAg+ transplanted patients has prompted us
to evaluate the long-term influence of HBAg+ on OS. Among the
248 transplantations (T) performed from 1969 through 1974, 121
grafts functioning for more than six months were selected. They
were subdivided into 60 HBAg— and 61 HBAg+ (17 of the latter
seroconverted during the first 12 months after T). OS after six
months became strikingly worse in the I-IBAg+ group than in the
HBAg— group (92 vs. 95% at one year, 83 vs. 85% at two years, 75
vs. 80% at three years, 60 vs. 80% at four years and 56 vs. 74% at
five years). This difference resulted solely from death of the recipi-
ent from hepatic failure and was not related to graft rejection. In
order to evaluate the potentially beneficial effect of HBAg+ early
after T, GS was analyzed in 129 patients in whom repeated HBAg
determinations were obtained prior to transplantation. The differ-
ence in GS between HBAg+ and HBAg— was minimal (76 vs. 70%
at six months, 72 vs. 68% at one year and 61 vs. 55% at two years).
It is concluded that HBAg+ at the time of T has little if any
influence on the early GS. Long-term and especially more than
three years after T, it implies an increased risk of death from HF.
Urinary tract infections after renal transplantation with special
respect to localization studies. V. Prât, V. Bohuslav, J. Jirka, I.
Hatala, M. Li.ka, P. Mâlek, K. Sliz and V. Koandrle. Institute of
Clinical and Experimental Medicine, Prague, Czechoslovakia. The
frequent association of renal transplantation and urinary tract
infection (UTI) is well known. Analysis of 80 patients confirmed
that the predisposing factors include immunosuppression, number
of treated rejection crises and catheterization. On the other hand,
no relation has been observed between UTI and abnormalities in
micturating cystogram and urogram, presence of autologous kid-
neys, duration of RDT and occurrence of posttransplant oliguria.
Despite their high incidence (over two-thirds of all patients) UTIs
manifested themselves mostly as a symptomatic bacteriuria and
have not been a significant cause of septicemia or death (less than
15% ofall deaths in the present series). Acute pyelonephritis in the
graft has been very rare as well. Localization studies (bladder
washout and diuretic test) have in the great majority of patients
demonstrated the infection to be confined to the lower urinary
tract. Antibody-coated bacteria have never been found in urinary
sediment. Residual bladder urine volume (measured by '311-hippu-
ran) was a frequent finding. This, along with surgical trauma with
ureterocystostomy, might explain the high incidence and frequent
recurrence of UT! in kidney graft recipients.
Treatment of chronic uremia by an ultrafiltration kidney: First
clinical experience. E. Quellhorst, B. Dohi, I. Rieger. Nephrologic
Center, Niedersachsen, Muenden. and University Hospital, Depart-
ment of Nephrology, Goettingen, Federal Republic of Germany.
Eight patients (pats) with various forms of chronic renal in-
sufficiency (ON, PN, diabetic nephropathy) and a GFR of 2.6 to 4
mI/mm were treated three times weekly for four to five hours each
with an artificial kidney, the principle of which is ultrafiltration
and substitution of filtrate by a modified Ringer's lactate solution
(about 20 liters per treatment). During 72 patient months, more
than 1000 ultrafiltration treatments were performed using this very
simple device (no dialysate is necessary). Molecules with a mol wt
of 1200 to 1500 (Vit. II 12, "peak 7") were eliminated to a greater
extent, urea and creatinine to a lesser extent than by hemodialysis.
In all pats nerve conduction velocity was augmented. In two pats
with intractable hypertension, during hemodialysis blood pressure
was normalized during a three-month filtration period without
lowering the body weight. Amino acid loss was the same as in
hemodialysis and lower than in peritoneal dialysis, After more
than one year of treatment, all pats are in good condition. Side
reactions have not been observed.
Metabolic fate of 14C-acetate during dialysis. S. J. Rorke, W.
Davidson, R. Morin and L. Guo, introduced by J. Coburn. Depart-
ments of Medicine and Pathology, Harbor General Hospital and
UCLA School of Medicine. Los A ngeles, California. The study was
undertaken to determine the metabolic fate of acetate (AC) during
dialysis. Six dogs were nephrectomized, then dialyzed for four
hours (Dow 4). Dialysis flow rate was 500 mI/mm; blood flow rate,
4 mI/mm/kg; AC concentration, 39.5 mm. AC-1-'4C was infused
into the venous line at 20 Ci/kg/4 hr. AC in blood and dialysate
was measured by gas chromatography. iaCo2 in expired air was
measured during dialysis and for eight hours after dialysis with an
electrometer and ion chamber. The dogs were killed and organs
removed for lipid assays. Results: AC rose to 10 to 20 mM in the
venous line and 2 to 4 m in the arterial line by the end of dialysis.
Arterial AC levels returned to normal (<0.5 mM) within 30 mm
after dialysis. Forty-nine percent of the infused AC-I-'4C could be
accounted for by expired '4C02 during the 12-hr study. Fifteen to
20% of the radioactivity was found in used dialysate. The remain-
der (30 to 35%) was assumed to have entered alternate metabolic
pathways, i.e., lipid biosynthesis. Small but significant quantities of
radioactivity were incorporated into lipids of liver and aorta, pri-
marily in the triglyceride and phospholipid fractions. Conclusion:
Significant quantities of AC delivered during dialysis are not im-
mediately metabolized to C02; some AC is incorporated into lipid.
The role of AC dialysis in the pathogenesis of the hypertriglyceri-
demia and accelerated atherogenesis in dialysis patients remains to
be determined.
Polymorphonuclear leukocyte (PMN) enzyme activity in human
glomerulonephritis E. Sanders, G. A. Coles and M. Davies.
KR. U.F. Institute, Royal Infirmary. Cardiff South Wales. A study
was undertaken to Investigate the possible involvement of PMN
lysosomal proteases in the pathogenesis of human glomerulone-
Abstracts 199
phritis. Urine samples from 150 patients with renal disease were
screened for proteases and glomérular basement membrane
(GBM) antigen, and total protein. Fourteen patients, all with
rapidly progressive or acute oliguric glomerulonephritis, excreted
acid and neutral proteases and GBM antigen. All had large num-
bers of glomerular PMNs on renal biopsy. Characterization of
these enzymes showed them to be identical to PMN lysosomal
proteases. Immunofluorescence revealed more than one type of
immunopathology. Clinical recovery, documented in three, was
accompanied by the disappearance of enzyme and antigen excre-
tion. Pure PMN elastase and neutral protease-positive urines were
capable of degrading human GBM in vitro. None of the above
findings could be demonstrated in normal volunteers or the other
patients. It is concluded that PMN lysosomal proteases are in-
volved in this type of glomerulonephritis.
25-OH vitamin D levels in the nephrotic syndrome. H. Schmidt-
Gayk. E. Ritz and B. Maschio. Department of Internal Medicine,
Heidelberg, Germany and Verona, Italy. Patients with a nephrotic
syndrome (NS) are known to have intestinal malabsorption of Ca
and hypocalciuria. Therefore, 25-OH-D levels were measured in 23
patients with the NS without renal insufficiency (urinary protein >
3.5 g/24 hr; GFR, 80 mI/mm )< 1.73 m2) using the assay of
Edelstein. 25-OH-D levels in the serum (month of August) were
20.3 + 9.4 nmoles/liter (normal range, 25 to ISO). 25-OH-D levels
were below the normal range in 16/23 patients. The study docu-
ments an acquired deficiency of circulating 25-OH-D in patients
with the nephrotic syndrome in the presence of normal GFR,
normal dietary intake and normal exposure to sunlight. Increased
renal loss of the low molecular weight binding protein is suggested
as the cause of low circulating 25-OH-D levels. It is unknown
whether the decrease of total 25-OH-D is accompanied by a de-
crease of free 25-OH-D and a concomitant failure of vitamin D
action on target organs although this is suggested by hypocalciuria
intestinal Ca malabsorption and a mineralization defect demon-
strable by electron microscopy.
Fourteen months' experience with the Hoeltzenbein dialyzer in
pediatric patients. H. W. Sch filer, R. Horsch, H. W. Asbach, K.
M5hring, U. Ikinger and L. Rfihl. Department of Urology, Surgical
Center, University of Heidelberg, Federal Republic of Germany.
Clinical experience is presented of four children on the Hoeltzen-
bein artificial kidney (HK), (152 plates; cuprophane, l0z; 0.92 m2
surface area; 75 ml priming volume) covering a period of 3 (one
child) to 14 months (three children). Three children between 5 and
13 yr of age had a creatinine clearance less than 1 ml/min/1.73 m2,
one child was anephric and all had previously been on dialysis for
one month to two years. Dialysis technique was short time 3 X 4 to
3 x 5 hr weekly. Average initial in vivo creatinine clearance of the
dialyzer ranged between 104 and 143 mI/mm depending on dialy-
sate degassing (QB, 200; Qo, 550 mI/mm). Ultrafiltration rate was
individually well adjustable and ranged from 0.5 to 3.0 kg per
dialysis. Residual blood volume measured by 'ttlndium labelled
red blood cells with an accuracy of +1% was 2.18 1.59 ml in 23
instances. Blood leak rate was 1/5 15. No transfusions were neces-
sary while the average hematocrit slightly increased. Physical well-
being of all children improved. Motor nerve conduction velocity
remained unchanged or increased. The HK proved practicable in
routine dialysis and was extremely well-accepted by the children.
Tubular histuria and serum proteinuria following kidney allotrans-
plantation. J. Scherberich, W. Mondorf W. Fassbinder and K. Koch.
Department of Nephrology, ZIM University Frankfurt/M. Federal
Republic of Germany. In order to study the pattern of histuria and
proteinuria in early graft rejection episode (RE) and acute tubular
necrosis (ATN) in the first two months after transplantation, ex-
cretion of indicator enzymes of the tubule (alanine aminopepti-
dase, 'y-glutamyl transpeptidase) and brush border membrane an-
tigens (BB) was followed in 36 patients by enzymatic and
immunological methods. In addition, excretion of /3-2-micro-
globulin, retinol-binding protein, light chains, a-l-glycoprotein,
prealbumin, albumin, IgG, fibrinogen, lIbrin(ogen) split products
D+E, 1gM and erythrocyte membrane antigens have been studied.
The recovery period after ATN had a different protein excretion
pattern compared to RE, where glomerular as well as tubular
patterns were observed. In ATN histuria correlated with diuresis (r
= 0.9, P < 0.005, N 8), in RE (N = 16), there was no correla-
tion. In ATN as well as in RE, urine samples revealed strong
immunoprecipitins against anti-BB sera; however, arrangement of
precipitates differed. Successful rejection therapy (N = 29) caused
prompt decrease in histuria. Persisting histuria was associated with
loss of the graft in five patients. Quantitative immunological deter-
mination of BB antigens in urine combined with evaluation of
serum proteinuria pattern appears to be a useful diagnostic tool to
separate RE from ATN and to predict the outcome of RE.
Dialysis-associated autoantibodies. S. Shaldon. M. Chevallet and
C. Mion. Service du Traitement de l'Insuffisance Rénale, Montpel-
her, France. The effect of dialyzer reuse on patient health was
investigated by determination of antinuclear antibodies and anti-
N-like cold agglutinins in 130 home and center dialysis patients
who had reused dialyzers for between one month and ten years.
The control population was 103 patients dialyzed without reuse in-
center for up to ten years. Positive antinuclear antibodies were
found in 9/87 reusers and 2/43 nonreusers (P <0.05) compared to
3/1000 healthy people; anti-N cold agglutinins were found in
21/130 reusers and 0/103 nonreusers (P < 0.001). The appearance
of these antibodies seems related to the duration of reuse, as no
patient was positive before six months of reuse. The mechanism
responsible for these antibodies may be the reinjection of white
blood cell nuclear debris and red blood cell envelopes attached to
the dialyzer membrane which may have been rendered immuno-
genic by the reuse procedure and sterilization with formalin. Clini-
ca! comparison of the two groups favored reusers as being better
rehabilitated, having higher PCV and fewer dialysis-related compli-
cations. To date no harmful effects have been demonstrated in
sensitized patients. However, the relation of these findings to trans-
plantation remains to be evaluated by a longitudinal study.
Australia and New Zealand renal transplantation survey. A. G. R.
Sheil and J. May, introduced by J. R. Johnson. Sydney, Australia.
Between 1963 and October, 1975, 2081 cadaver kidney grafts have
been performed in 1843 patients in Australia and New Zealand.
Most recipients (1550, 84%) were between the ages of 16 and 50 yr.
Of the 1843 patients, 1176 (64%) survive, 975 (47%) with function-
ing grafts. Mean duration of survival is 4.2 yr. Successful function
at five years was observed in 42% of grafts. Two hundred eighteen
patients had secondary grafts, 103 (47%) successfully. Patients
successfully treated by primary or secondary grafts were 50% at
four years and 40% at eight years. Of patients who received suc-
cessful grafts, the greater majority (80%) were fully rehabilitated to
work or household duties. Major reasons for failure were rejection
and infection and other complications of immunosuppressive
drugs. The incidence of malignant tumor development in trans-
plant recipients is currently 8% overall and almost one-quarter in
patients who were transplanted between five and ten years ago.
Maintenance hemodialysis (H) in diabetic patients (DP). Robert
F. Sh,jkin, Martin Neff. A ndres Baez, Surrendra Gupta. Nirmal
Mattoo and Moshe Haimov. The Mt. Sinai School of Medicine of
the City University of New York, City Hospital at Elmhurst, Elm-
hurst, New York. We have dialyzed 90 DP, ages 19 to 73 yr, 52
males and 38 females. Duration of H has been from Ito 82 months
for a total of 1914 patient months. Fifty-seven were adult-onset (A)
and 33 juvenile-onset (J) diabetics. For most DP insulin needs
increased once regular H started. Thirty-nine percent of J and 21%
of A were bilaterally blind (BB) at onset of H. Another 22% of J
became BB in the first year of H. Neuropathy (N) was present in
almost all patients and rarely improved with H. Seventy-five
patients were dialyzed at an outpatient satellite unit and 15 at
home. There were 41 deaths, 17 of them occurring during the first
year. Causes of death were infection, 10; myocardial infarction, 10;
cerebrovascular accident, 9; pericarditis, 2; withdrawal from H, I.
After the first year their clinical course was stable. Access to the
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circulation was not an overwhelming problem. Hospitalizations
were for diabetic problems, arteriosclerotic vascular disease and
infections mainly. One- and two-year cumulative survival rates for
J were 84% and 63%; for A, 77% and 61%.
Lymphocyte-dependent antibody (LDA) and human chronic allo-
graft rejection (CR) J. Thomas, F. Thomas and H. M. Lee. Depart-
ment of Surgery, Medical College of Virginia, Richmond, Virginia.
There is currently no effective treatment for CR since the immu-
nopathology of the syndrome is poorly understood. Recipients
developing CR from three months to 14 yr after transplantation
had longitudinal LDA studies using fresh and frozen sera, Meth-
ods: In 36 patients, LDA studies were performed according to the
method of Trinchieri et al. Appropriate controls were included in
all cases. Of 17 patients with clinical signs of CR. 15, or 88%, had a
positive LDA test, whereas only one of 19 (5%) recipients without
CR had a positive LDA (P < 0.05). In addition, retrospective
studies using frozen sera indicated that nine of nine (100%) of
patients with CR had LDA activity in their serum 0.2 to 6 yr prior
to Onset of clinical CR. Of three patients having LDA activity
before transplantation, all three subsequently developed CR.
These studies, as well as previous studies of CR in our patients,
suggest that LDA is a causal factor in CR. In these studies, the
early appearance of LDA prior to the onset of clinical CR supports
our previous hypothesis of a causal role of LDA in CR. The
occurrence of CR in patients with demonstrable LDA before trans-
plantation suggests that patients should be screened for LDA
before transplantation. Posttransplant monitoring for LDA may
detect immunological activity prior to the onset of clinical symp-
toms. Pharmacological modulation of recipient LDA and K cell
cytotoxicity may be monitored by these in Vitro studies.
Specific CML defect in ten-year successful HLA nonidentical
renal transplant recipients. F. Thomas, J. Thomas and H. M. Lee.
Department of Surgery, Medical College of Virginia, Richmond,
Virginia. The precise immunological mechanisms by which HLA
nonidentical transplants (NIT) are well tolerated for up to ten
years or more are not known. In this study, mixed lymphocyte
culture (MLC), cell-mediated lympholysis (CML) and serum-
blocking factors were measured in 30 NIT recipients at ten years.
Results: All patients were MLC-responsive to their donors. Spe-
cific antidonor MLC serum blocking activity was found in 60% of
NIT recipients. In CML studies performed in normal serum, 25 of
30 (86%) successful NIT recipients demonstrated a specific defect
in ability to generate cytotoxic T cells in vitro to the allograft donor
while demonstrating a normal CML response to third party cells,
thus ruling Out an immunosuppressive drug effect. Suppressor cell
activity was demonstrated in 38% of recipients. Conclusions: These
studies showed that the population of long-term successful NIT
recipients studied is not tolerant to the allograft donor at the M LC
level. However, the serum of most recipients exhibited significant
MLC blocking activity. In addition, 81% were unable to generate
cytotoxic effector T cells to the donor suggesting that this may be a
previously unappreciated mechanism of long-term graft survival
since the defect is seen in only 38% of recipients at two to five years
after transplantation and in less than 3% of unsuccessful noniden-
tical transplants.
Factors influencing patient (P) and graft (G) survival in kidney
transplantation. P. Vereerstraelen, R. d'Orchimont, E. Dupont, F.
Dupuis, P. Kinnaert, J. Van Geeriruyden and C. Toussaint. Dept.
Nèphrologie, Hpita1 Unirersitaire. Brussels, Belgium. G and P
survivals were analyzed for 235 (212 cadaveric and 23 parental)
kidney transplantations performed in the same institution from
January, 1965 to December, 1975. The following factors exerted no
significant effects on P and 0 survivals: origin of graft (parental vs.
cadaveric), order of transplants (first vs. second), HL-A matching,
duration of dialysis, number of blood transfusions, sex and
primary renal disease, donor's age, amount of antilymphocyte
globulin administered. Patient's presensitization decreased P and
0 survivals, but this effect was significant only for 0 survival when
the crossmatch was performed not on the serum collected just prior
to transplantation, but on the serum sample with the highest
lymphocytotoxic titer. Recipient's age influenced P and 0 surviv-
als, older patients showing higher failure rates. Transient or
chronic hepatitis B antigen carried-state improved P and G surviv-
als. When compared to the 1965 to 1972 period, mortality was
lower during the 1973 to 1975 period, this being presumably due to
decreased dosage of immunosuppressive drugs.
Nine-hour peritoneal dialysis three times weekly: An alternative to
conventional hemodialysis. B. von Hartitzsch, T. R. Medlock. Hill-
crest Medical Center, Tulsa, Oklahoma. Many patients with
chronic uremia are still denied therapy because of limited hemo-
dialysis facilities. Few have considered peritoneal dialysis as a
practical long-term alternative. By using an indwelling catheter,
nine-hour peritoneal dialysis three times weekly can be accom-
plished efficiently in an outpatient area. Experience spanning two
years, 30 patients (26 to 80 yr), 280 patient months and 3480
peritoneal dialyses is reported. Data from nine patients treated for
more than three months in our parallel regimes of peritoneal
dialysis, 3 X 9 hr (541 liters) weekly, and hemodialysis, 3 X 5 hr,
with conventional coil dialysis showed no significant difference in
predialysis BUN, creatinine, uric acid, P, Na and K between the
two regimes, Significantly higher HCO3 levels occurred with per-
itoneal dialysis. Significantly lower serum albumin occurred in
peritoneal patients. Hematocrit levels tended to be higher due to
the absence of blood loss. Young, old and juvenile onset diabetics
(eight) tolerated the peritoneal treatments well. Patients tended to
be adequately rehabilitated. Positive peritoneal cultures were ob-
tained in 10/1000 with overt symptoms in 2/1000. Mean catheter
survival is 4.4 months with infection responsible for one-half the
catheter replacements. Sixty-seven percent of all peritoneal in-
fections were by eoag. neg. Staphylococcus. Our experience in-
dicates peritonea! dialysis nine hours three times weekly is an
effective alternative to conventional hemodialysis. We believe It to
be the treatment of choice for diabetic and older patients.
Dialysis encephalopathy syndrome. M. K. Ward, A. M. Pierides,
P. Fawcett. D. A. Shaw. R. H. Perry, B. E. Tomlinson andD. N. S.
Kerr. University of Newcastle-upon-Tyne, England. Between Janu-
ary, 1974 and December, 1975, a rapidly progressive neurological
disorder has been seen in ten patients receiving intermittent hemo-
dialysis. The initial presentation has been the development of
slurring and indistinct speech which is first recognized at the end of
a dialysis period. Additional neurological signs develop. These
include dysphasia, dyspraxia, personality changes, hallucinations,
cerebellar dysfunction, global dementia and myoclonic spasms.
Seven patients were male, three female (mean age, 36 yr: range, 26
to 52 yr). Duration of dialysis was 31.6 months (range, 16 to 60
months). Six patients have died of this syndrome. Macroscopically
the brains had no pathological features. Examination of central
nervous system tissue has revealed abnormalities in the cerebral
cortex, brain stem and cerebellum. Many cortical neurones are
degenerate and neurone depletion is present (particularly in the
cerebellum). All ten patients were on a regimen of aluminum
hydroxide and had evidence of a proximal myopathy associated
with bone pain. Eight patients had pathological fractures. Severe
osteomalacia associated with a normal serum alkaline phosphatase
was present in eight patients who had a bone biopsy. There appears
to be a strong association between aluminum hydroxide-induced
"hypophosphatemic" osteomalacia and this neurological syn-
drome. The aluminum content of brain gray matter is being meas-
ured.
Atypical glomerular disease in diabetes mellitus. J. A. Wass, P. J.
Watkins, F. E. Dische and V. Parsons. Renal Unit and Departments
of Medicine and Pathology, King's College Hospital, London, Eng-
land. Eight patients with diabetes mellitus presented with pro-
teinuria, but only one had proliferative retinopathy while the evo-
lution of the renal disease was atypical of diabetic nephropathy.
Proteinuria was excessive in some patients in relation to the evolu-
tion of their diabetes. Renal biopsy showed diabetic changes in
only one patient with signs of acute glomerulonephritis (one), gb-
merular mesangial proliferation (two), chronic gbomerulonephritis
(one), amyboidosis (one) and systemic lupus erythematosus (one).
One young patient with highly selective but heavy proteinurla was
not biopsied and responded well to steroids and one course of
cyclophosphamide without relapse. It is concluded that biopsy
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should be performed in diabetes mellitus when the renal disease is
unaccompanied by advanced retinopathy, neuropathy and arteri-
opathy. It is important to distinguish this group of atypical
patients, because in typical diabetic renal disease, heavy pro-
teinuria and the development of renal failure carry a poor progno-
sis leading to the consideration of dialysis or transplantation.
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